The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms

R Meech, DG Hu, RA McKinnon… - Physiological …, 2019 - journals.physiology.org
UDP-glycosyltransferases (UGTs) catalyze the covalent addition of sugars to a broad range
of lipophilic molecules. This biotransformation plays a critical role in elimination of a broad …

[PDF][PDF] Phase II drug metabolizing enzymes

P Jancova, P Anzenbacher… - Biomed Pap Med Fac Univ …, 2010 - Citeseer
Background. Phase II biotransformation reactions (also 'conjugation reactions') generally
serve as a detoxifying step in drug metabolism. Phase II drug metabolising enzymes are …

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

EP Allain, M Rouleau, E Lévesque… - British journal of …, 2020 - nature.com
The best-known role of UDP-glucuronosyltransferase enzymes (UGTs) in cancer is the
metabolic inactivation of drug therapies. By conjugating glucuronic acid to lipophilic drugs …

[图书][B] Hayes' principles and methods of toxicology

AW Hayes, T Kobets - 2023 - taylorfrancis.com
Hayes' Principles and Methods of Toxicology has long been established as a reliable and
informative reference for the concepts, methodologies, and assessments integral to …

Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily

PI Mackenzie, KW Bock, B Burchell… - Pharmacogenetics …, 2005 - journals.lww.com
Several novel UDP glycosyltransferase (UGT) genes, mainly UDP glucuronosyltransferases,
have been identified in the human, mouse and rat genomes and in other mammalian …

[HTML][HTML] Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug …

M Kozyra, M Ingelman-Sundberg, VM Lauschke - Genetics in Medicine, 2017 - Elsevier
Purpose In this study we characterized the genetic variability of 146 clinically relevant genes
influencing drug pharmacokinetics in African and European subpopulations, which are key …

UDP-glucuronosyltransferases and clinical drug-drug interactions

TKL Kiang, MHH Ensom, TKH Chang - Pharmacology & therapeutics, 2005 - Elsevier
UDP-glucuronosyltransferase (UGT) enzymes catalyze the conjugation of various
endogenous substances (eg, bilirubin) and exogenous compounds (eg, drugs). The human …

Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines

RJ Turesky, L Le Marchand - Chemical research in toxicology, 2011 - ACS Publications
Aromatic amines and heterocyclic aromatic amines (HAAs) are structurally related classes of
carcinogens that are formed during the combustion of tobacco or during the high …

Molecular mechanism of phase I and phase II drug‐metabolizing enzymes: implications for detoxification

T Iyanagi - International review of cytology, 2007 - Elsevier
Enzymes that catalyze the biotransformation of drugs and xenobiotics are generally referred
to as drug‐metabolizing e nzymes (DMEs). DMEs can be classified into two main groups …

Metabolism of green tea catechins: an overview

W Yong Feng - Current drug metabolism, 2006 - ingentaconnect.com
Green tea is one of the most popular beverages worldwide. Its major components include (-)-
epicatechin ((-)-EC),(-)-epicatechin-3-gallate (ECG)(-)-epigallocatechin (EGC) and (-) …